Literature DB >> 17634467

Rational design of cancer-drug combinations.

Sridhar Ramaswamy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634467     DOI: 10.1056/NEJMcibr072593

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.

Authors:  Angelique W Whitehurst; Yang Xie; Scott C Purinton; Kathryn M Cappell; Jackie T Swanik; Brittany Larson; Luc Girard; John O Schorge; Michael A White
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

2.  Desmosomal interactome in keratinocytes: a systems biology approach leading to an understanding of the pathogenesis of skin disease.

Authors:  Nicola Cirillo; Stephen S Prime
Journal:  Cell Mol Life Sci       Date:  2009-11       Impact factor: 9.261

Review 3.  Efficacy-oriented compatibility for component-based Chinese medicine.

Authors:  Jun-hua Zhang; Yan Zhu; Xiao-hui Fan; Bo-li Zhang
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

4.  Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.

Authors:  Lifang Xie; Michelle Kassner; Ruben M Munoz; Qiang Q Que; Jeff Kiefer; Yu Zhao; Spyro Mousses; Hongwei H Yin; Daniel D Von Hoff; Haiyong Han
Journal:  Biochem Pharmacol       Date:  2011-11-15       Impact factor: 5.858

5.  Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles.

Authors:  Yingchao Han; Zhijian He; Anita Schulz; Tatiana K Bronich; Rainer Jordan; Robert Luxenhofer; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2012-06-28       Impact factor: 4.939

6.  Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.

Authors:  Miriam B Brandl; Eddy Pasquier; Fuhai Li; Dominik Beck; Sufang Zhang; Hong Zhao; Maria Kavallaris; Stephen T C Wong
Journal:  Mol Oncol       Date:  2014-06-19       Impact factor: 6.603

7.  Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.

Authors:  H Ehrhardt; L Pannert; S Pfeiffer; F Wachter; E Amtmann; I Jeremias
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Systematic quantitative characterization of cellular responses induced by multiple signals.

Authors:  Ibrahim Al-Shyoukh; Fuqu Yu; Jiaying Feng; Karen Yan; Steven Dubinett; Chih-Ming Ho; Jeff S Shamma; Ren Sun
Journal:  BMC Syst Biol       Date:  2011-05-30

9.  Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma.

Authors:  Hátylas Azevedo; Carlos Alberto Moreira-Filho
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

10.  Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.

Authors:  Jing Tang; Leena Karhinen; Tao Xu; Agnieszka Szwajda; Bhagwan Yadav; Krister Wennerberg; Tero Aittokallio
Journal:  PLoS Comput Biol       Date:  2013-09-12       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.